CCL2 and neoplasm: TNFα has been identified as a proinflammatory cytokine that kills tumor cells and microorganisms, but it has also been suggested to lower insulin sensitivity through induction of inflammatory molecules such as MCP1 and IL-6 and through the reduction of adiponectin expression [20,24].